Get started

Nyse

Live Challenging NYSE Stock Market Analysis Buy GME @ 185.00 Live Challenging NYSE Stock Market Analysis Buy GME @ 185.00 Target @ 349.75 Our Unique Features: ————————————————————— 1. Follow our 15 signals ….10% equity will increase in your account for sure. 2. We are not Trailing stop! or average the trades. 3. 2% Risk Management Per trade. 4. Risk vs Reward up to 1:7. Note: Trade signals would usually have a risk to reward ratio of 1:2. It means that even 2 out of 4 signals hits their SL marks, the other two would have closed with profit. This allows you to be good in overall pips profit. Signals are usually inter-day (Based on the daily candle) therefore, trades would usually have a holding time of an average minimum of 24 hours. Note: Everything works with Best money management. Note: Please leave comments for any query. Disclaimer: This is my trading experience, it is not an invite or recommendation to trade. Best Wishes Forex Tamil
NYSE:GME
by Tradingwithtamil
1
Coca Cola may get bitter here!The stock is in a dominant trend up. Recently a lower high and lower low price pattern has been noticed on the daily charts. The RSI also seems to have shifted the range from bullish 80-40 zones to neutral 60-40 zones in the past few weeks. Important support levels are marked on the charts. Breaking them may result into corrections. The degree of the corrections are still not predictable, but the RSI forewarns. To get more insights into RSI visit www.prorsi.com
NYSE:KOShort
by BharatJhunjhunwala
ImmunoPrecise Antibodies Stock AnalysisQuote: #IPA/#IPATF Buy Target:$0.80/$0.60 (don’t bet the house here looking for a quick scalp) Sell Target: $1.00 Description: ImmunoPrecise Antibodies Ltd. engages in antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services. The company has a collaboration agreement with TetraGenetics, Inc. The company was founded in 1989 and is based in Victoria, Canada. Please follow us on our facebook and twitter. Subscribe to our newsletter to get analysis directly to your mail. Facebook - @SFYBUofficial Twitter - @SFYBUoffical
ILong
by SFYBUofficial
IMAX Stock analysis long termCompany: Imax Quote: #IMAX Buy Target: TBD pending on price action and tapes into earnings Sell Target: $28-$30 Next Earnings date: April 26th This Is a 20% gainer we missed last Q from being to conservative we will be looking for an entry ether before or after earnings all pending on the tape such a small float it will be a good read reading the tapes into Friday to see which way this name is going to trade. Description: IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company that specializes in motion picture technologies and presentations worldwide. It offers cinematic solution comprising proprietary software, theater architecture, and equipment. The company engages in Digital Re-Mastering (DMR) of films into the IMAX format for exhibition in the IMAX theater network; the provision of IMAX premium theater systems to exhibitor customers through sales, long-term leases, and joint revenue sharing arrangements; the distribution of documentary films; the provision of production technical support and film post-production services; the ownership and operation of IMAX theaters; and the provision of camera and other miscellaneous items rental services. It also designs, manufactures, installs, sells, and leases IMAX theater projection system equipment; maintains IMAX theater projection system equipment in the IMAX theater network; distributes and licenses original content investment, IMAX home entertainment, and others; and sells or leases its theater systems to theme parks, private home theaters, tourist destination sites, fairs, and expositions, as well as engages in the after-market sale of projection system parts and 3D glasses. The company markets its theater systems through a direct sales force and marketing staff. It owns or otherwise has rights to trademarks and trade names, which include IMAX, IMAX Dome, IMAX 3D, IMAX 3D Dome, Experience It in IMAX, The IMAX Experience, An IMAX Experience, An IMAX 3DExperience, IMAX DMR, DMR, IMAX nXos, IMAX think big, think big, and IMAX Is Believing, as well as the service mark IMAX THEATRE. As of December 31, 2018, the company had a network of 1,505 IMAX theater systems comprising 1,409 commercial multiplexes, 14 commercial destinations, and 82 institutional facilities operating in 80 countries. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada. Short Interest: Short Percent of Float 5.86% Short percent of increase or Decrease -4% Analysis Ratings : Stock price Target #IMAX High : $34 Median : $27 Low : $21.50 Average : $27.04 Current Price : $25.33 Feb 25 - 19 Downgrade Canaccord Genuity Buy - Hold $23 Apr 25 - 19 Upgrade The Benchmark Company Hold - Buy $28 Feb 28 - 18 Reiterated B. Riley FBR, INC. Buy $35-$37.75 Tapes last week: 3/5 wouldve gotten a one however the last two days were very bullish Please our Facebook and Twitter for more updates.Please subscribe to our Newsletter for more information Facebook - @SFYBUofficial Twitter - @SFYBUofficial
NYSE:IMAXLong
by SFYBUofficial